NCT07287631 Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
| NCT ID | NCT07287631 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abbott Point of Care |
| Condition | Hematologic Tests |
| Study Type | INTERVENTIONAL |
| Enrollment | 425 participants |
| Start Date | 2025-09-17 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 425 participants in total. It began in 2025-09-17 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assess precision of the i-STAT potassium (K) and ionized calcium (iCa) tests using i-STAT CG8+ cartridge on the i-STAT 1 analyzer.
Eligibility Criteria
Inclusion Criteria: 1. Signed and dated consent form (waiver/alteration of consent, waiver of documentation of consent may be acceptable, per IRB) 2. ≥ 18 years of age Exclusion Criteria: 1\. Previous enrollment in this study
Contact & Investigator
Manish Gupta, MS, MBA
STUDY DIRECTOR
Abbott Point of Care
Frequently Asked Questions
Who can join the NCT07287631 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematologic Tests. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07287631 currently recruiting?
Yes, NCT07287631 is actively recruiting participants. Contact the research team at miranda.gonzalezaguirre@abbott.com for enrollment information.
Where is the NCT07287631 trial being conducted?
This trial is being conducted at Albuquerque, United States, Hershey, United States, Milwaukee, United States.
Who is sponsoring the NCT07287631 clinical trial?
NCT07287631 is sponsored by Abbott Point of Care. The principal investigator is Manish Gupta, MS, MBA at Abbott Point of Care. The trial plans to enroll 425 participants.